MOLLY LOUDERBACK: Open Payments
NPI 1245800846 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 21 payments from 12 companies in 2025. Trend: 2023 $985 · 2024 $1,306 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $143 |
| ABBVIE INC. | 5 | $90 |
| ARGENX US, INC. | 2 | $64 |
| Alexion Pharmaceuticals, Inc. | 3 | $62 |
| SANOFI-AVENTIS U.S. LLC | 2 | $29 |
| Lundbeck LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| EMD Serono, Inc. | 1 | $18 |
Products named: INGREZZA, VYVGART HYTRULO, ULTOMIRIS, UBRELVY, QULIPTA, TZIELD, VYEPTI, REXULTI.
Industry payments across TN — which companies pay providers there.
